Cargando…
A revised road map for the commitment of human cord blood CD34-negative hematopoietic stem cells
We previously identified CD34-negative (CD34(−)) severe combined immunodeficiency (SCID)-repopulating cells as primitive hematopoietic stem cells (HSCs) in human cord blood. In this study, we develop a prospective ultra-high-resolution purification method by applying two positive markers, CD133 and...
Autores principales: | Sumide, Keisuke, Matsuoka, Yoshikazu, Kawamura, Hiroshi, Nakatsuka, Ryusuke, Fujioka, Tatsuya, Asano, Hiroaki, Takihara, Yoshihiro, Sonoda, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989201/ https://www.ncbi.nlm.nih.gov/pubmed/29875383 http://dx.doi.org/10.1038/s41467-018-04441-z |
Ejemplares similares
-
TGF-β Signaling Accelerates Senescence of Human Bone-Derived CD271 and SSEA-4 Double-Positive Mesenchymal Stromal Cells
por: Kawamura, Hiroshi, et al.
Publicado: (2018) -
Human cord blood-derived primitive CD34-negative hematopoietic stem cells (HSCs) are myeloid-biased long-term repopulating HSCs
por: Matsuoka, Y, et al.
Publicado: (2015) -
CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells
por: Takahashi, M, et al.
Publicado: (2014) -
Commitment and innovation on the road to people-centred PHC financing
por: Brown, Gordon, et al.
Publicado: (2022) -
Multipotent and Committed CD34(+) Cells in Bone Marrow Transplantation
por: Ema, Hideo, et al.
Publicado: (1991)